Consent Decree Orders FDA Action On Triclosan OTC Monographs
This article was originally published in The Tan Sheet
Executive Summary
A Nov. 21 consent decree sets multiple deadlines over a five-year period to make FDA finalize its OTC topical antimicrobial drug products monograph with respect to triclosan. Under one deadline of note to triclosan product makers, the agency must publish a tentative final monograph for consumer antiseptic hand wash products by Dec. 16, with a final monograph due by Sept. 15, 2016.
You may also be interested in...
Here's The 'Rub' On Antiseptic Washes: FDA Wants Additional Safety, Efficacy Data
FDA says in a proposed rule that it currently does not intend to remove any products containing alcohol or benzalkonium from the market, but asks firms that want to continue marketing the products to submit additional GRAS/GRAE data on the ingredients.
Here's The 'Rub' On Antiseptic Washes: FDA Wants Additional Safety, Efficacy Data
FDA says in a proposed rule that it currently does not intend to remove any products containing alcohol or benzalkonium from the market, but asks firms that want to continue marketing the products to submit additional GRAS/GRAE data on the ingredients.
Cold Indication For Antihistamine Monograph Expected This Year – DNDP Director Michele
FDA this year will publish an antihistamine monograph rule stemming from a partnership with Canada, says Theresa Michele, director of the Division of Nonprescription Drug Products. At a recent CHPA conference, Michele suggested FDA will parlay strong momentum and internal improvements from 2015 into 2016 progress.